Medifast, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount
Medifast, Inc. (MED) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount of $163.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2017-03-16
- Medifast, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, amount for fiscal 2016 was $163.00K, a 34.01% decline from fiscal 2015.
- Medifast, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, amount for fiscal 2015 was $247.00K, a 21.67% increase from fiscal 2014.
- Medifast, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, amount for fiscal 2014 was $203.00K, a 55.77% decline from fiscal 2013.
- Medifast, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, amount for fiscal 2013 was $459.00K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount 12 month as first filed |
|---|---|---|
| 2016-12-31 | $163.00K 10-K · filed 2017-03-16 | |
| 2015-12-31 | $247.00K 10-K · filed 2017-03-16 | |
| 2014-12-31 | $203.00K 10-K · filed 2017-03-16 | -$203.00K 10-K · filed 2015-03-16 |
| 2013-12-31 | $459.00K 10-K · filed 2016-03-15 | -$459.00K 10-K · filed 2014-03-17 |
| 2012-12-31 | -$267.00K 10-K · filed 2015-03-16 | |
| 2011-12-31 | -$336.00K 10-K · filed 2014-03-17 | |
| 2010-12-31 | $0.00 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COFFEE HOLDING CO INC (JVA) | United States | $0.023B | 4.10 |